| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 541.474 | 92 |
| GSM780708 | Untreated after 4 days (C2_1) | 380.598 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 378.711 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 518.593 | 92 |
| GSM780720 | Untreated after 4 days (C2_2) | 436.785 | 91 |
| GSM780721 | Untreated after 4 days (C3_2) | 358.085 | 89 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 382.954 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 469.551 | 91 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 526.392 | 92 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 378.8 | 89 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 456.354 | 91 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 534.514 | 92 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 472.94 | 91 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 426.23 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 432.038 | 90 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 453.422 | 91 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 376.844 | 89 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 463.464 | 91 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 511.454 | 92 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 489.402 | 91 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 483.165 | 91 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 470.575 | 91 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 465.691 | 91 |